Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Associations Between Social Determinants of Health and Adherence to Biologic Therapies in Patients with Severe Asthma: Real-World Evidence from a Large US Claims Analysis.
Journal: Journal of asthma and allergy
Published: March 20, 2026
High Systemic Corticosteroids Burden Among Moderate-to-Severe Asthma Patients in the United States.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 06, 2026
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
Journal: Journal of asthma and allergy
Published: February 10, 2026
The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.
Journal: The journal of allergy and clinical immunology. Global
Published: October 20, 2025
Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group Study.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 09, 2025
Critical flaws in: "Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study".
Journal: The European respiratory journal
Published: July 25, 2025
Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 23, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics.
Journal: American journal of respiratory and critical care medicine
Published: May 18, 2025
Characteristics, treatment patterns, healthcare resource utilization, and costs in patients with eosinophilic esophagitis in the United States: a retrospective analysis of insurance claims data.
Journal: Therapeutic advances in gastroenterology
Published: May 05, 2025
Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication.
Journal: Immunotherapy
Published: February 11, 2025
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 25, 2024
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update.
Journal: Tuberculosis and respiratory diseases
Published: December 23, 2024
Last Updated: 09/26/2026